학술논문

Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital
Document Type
Report
Source
International Journal of Antimicrobial Agents. July, 2009, Vol. 34, pS30
Subject
Staphylococcus aureus infections -- Care and treatment
Staphylococcus aureus infections -- Health aspects
Cross infection -- Care and treatment
Cross infection -- Health aspects
Nosocomial infections -- Care and treatment
Nosocomial infections -- Health aspects
Staphylococcus aureus -- Health aspects
Language
English
ISSN
0924-8579
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0924-8579(09)70547-3 Byline: Silvano Esposito (a), Sebastiano Leone (a)(b), Ester Petta (a), Silvana Noviello (a), Filomena Ianniello (a) Keywords: Meticillin-resistant Staphylococcus aureus; Skin and soft tissue infections; Oral administration; Parenteral administration; Outpatient parenteral therapy Abstract: Although meticillin-resistant Staphylococcus aureus (MRSA) is recognized as a significant cause of nosocomial infections, it is also becoming an increasingly common cause of infections in the community. Overall, the most common infections caused by MRSA are those involving the skin and skin structures. These infections are difficult to treat and are associated with high morbidity and substantial cost. This article summarizes the current oral and parenteral therapeutic options, of which there are several, and the optimal site of care for the management of these infections. Defining the severity of the illness is central to improving the decision-making process about the route of administration and site of care. Author Affiliation: (a) Department of Infectious Diseases, Second University of Naples, Naples, Italy (b) Department of Infectious Diseases, San Giuseppe Moscati Hospital, Avellino, Italy